These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 19841026
1. The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease. Thakkar BV, Hirsch AT, Satran D, Bart BA, Barsness G, McCullough PA, Kennard ED, Kelsey SF, Henry TD. Vasc Med; 2010 Feb; 15(1):15-20. PubMed ID: 19841026 [Abstract] [Full Text] [Related]
3. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Soran O, Kennard ED, Kfoury AG, Kelsey SF, IEPR Investigators. Am J Cardiol; 2006 Jan 01; 97(1):17-20. PubMed ID: 16377276 [Abstract] [Full Text] [Related]
13. Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. Soran O, Ikizler C, Sengül A, Cuğlan B, Kennard E, Kelsey S. Turk Kardiyol Dern Ars; 2012 Jun 01; 40(4):323-30. PubMed ID: 22951848 [Abstract] [Full Text] [Related]
14. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry. Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS, ARRIVE 1 Participating Physicians. Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):433-45. PubMed ID: 18814217 [Abstract] [Full Text] [Related]
17. Effect of enhanced external counterpulsation on resting oxygen uptake in patients having previous coronary revascularization and in healthy volunteers. Ochoa AB, deJong A, Grayson D, Franklin B, McCullough P. Am J Cardiol; 2006 Sep 01; 98(5):613-5. PubMed ID: 16923446 [Abstract] [Full Text] [Related]
19. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Rajaram SS, Shanahan J, Ash C, Walters AS, Weisfogel G. Sleep Med; 2005 Mar 19; 6(2):101-6. PubMed ID: 15716213 [Abstract] [Full Text] [Related]
20. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry. Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y, REduction of Atherothrombosis for Continued Health Registry Investigators. J Neurol Sci; 2009 Dec 15; 287(1-2):45-51. PubMed ID: 19815240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]